NDC 50242-142 – Lunsumio

Mosunetuzumab 30 mg/30mL · Concentrate · Intravenous

Human Prescription Drug

Product NDC50242-142

Product details

Brand name
Lunsumio
Generic name
Mosunetuzumab
Labeler
Genentech, Inc.
Dosage form
Concentrate
Route
Intravenous
Marketing category
BLA · BLA761263
Marketed since
December 22, 2022
Listing expires
December 31, 2027

Active ingredients

Uses, dosage, side effects and warnings for Lunsumio →

Package NDC codes (1)

Package NDCDescriptionSince
50242-142-011 VIAL in 1 CARTON (50242-142-01) / 30 mL in 1 VIALDec 22, 2022

Other Lunsumio products